CasLoc logo
All Cases PTAB Litigations UPC Oppositions

IGI Laboratories Inc. v. Mallinckrodt LLC

1:13-cv-02044

Overview

Case Number 1:13-cv-02044
Filing Date 2013-12-19
Status Terminated
Termination Date 2014-06-26
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Nuvo Research Inc. Operating Company

Represented By

2 Attorneys Listed

Frederick L. Cottrell , III

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Mallinckrodt Inc. Operating Company

Represented By

2 Attorneys Listed

Frederick L. Cottrell , III

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Mallinckrodt LLC Operating Company

Represented By

2 Attorneys Listed

Frederick L. Cottrell , III

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Plaintiff

IGI Laboratories Inc. Operating Company

Represented By

4 Attorneys Listed

Shane A. Brunner

Email: sbrunner@merchantgould.com

Edward J. Pardon

Email: epardon@merchantgould.com

Benjamin J. Schladweiler

Greenberg Traurig, LLP

Tel: +1 (302) 661-7394

The Nemours Building, 1007 North Orange Street, Suite 1200

Collins J. Seitz , Jr.

Seitz Ross Aronstam & Moritz LLP

Tel: +1 (302) 576-1600

100 S. West Street, Suite 400, Wilmington, DE 19801

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 3 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (3 found):
U.S. Courts: 3
U.S. District Court 2014-12-23
1:14-cv-07992

HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES, UT, INC.

Asserted Patent
Status: NJD
U.S. District Court 2013-03-28
1:13-cv-00494

Mallinckrodt LLC v. Taro Pharmaceutical Industries Ltd.

Asserted Patent
Status: DED
U.S. District Court 2012-08-30
1:12-cv-01087

Mallinckrodt LLC v. Lupin Ltd

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8217078
Treatment of pain with topical diclofenac
Filed: 2010-10-28
Issued: 2012-07-10
Active (3.9 yrs remaining)
Expires: 2030-10-28
US8546450
Treatment of pain with topical diclofenac compounds
Filed: 2009-07-10
Issued: 2013-10-01
Active (3.7 yrs remaining) +395d PTA
Expires: 2030-08-09

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

14

Dispositive

9

Granted

1

Denied

0

Pending / Review

11

Motions by Category

Motion to Dismiss (FRCP 12(b)(6)) 6 Procedural / Extension Motion 5 Motion to Dismiss 3

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
MEMORANDUM ORDER Granting in part and Denying in part 15 MOTION to Dismiss. Counterclaims II and IV are Dismissed. Signed by Judge Richard G. Andrews on 4...
Entry #24 • 2014-04-22 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
REQUEST for Oral Argument by Mallinckrodt Inc., Mallinckrodt LLC, Nuvo Research Inc. re 15 MOTION to Dismiss Counterclaim Pursuant to Rule 12(b)(6). (Lester, Ka...
Entry #23 • 2014-03-24 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
REPLY BRIEF to 15 Motion to Dismiss Counterclaim Pursuant to Rule 12(b)(6), filed by IGI Laboratories Inc.. (Schladweiler, Benjamin) Modified on 3/21/2014 (nms)...
Entry #22 • 2014-03-20 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
ANSWERING BRIEF in Opposition re 15 MOTION to Dismiss Counterclaim Pursuant to Rule 12(b)(6) filed by Mallinckrodt Inc., Mallinckrodt LLC, Nuvo Research Inc..Re...
Entry #21 • 2014-03-05 Document →
Motion to Dismiss Pending / Under Review
STIPULATION TO EXTEND TIME for Defendants to file their Answering Brief to IGI's Motion to Dismiss Counterclaim to March 5, 2014 and for IGI to file its Reply B...
Entry #20 • 2014-02-14 Document →
Motion to Dismiss Pending
SO ORDERED, re 20 STIPULATION TO EXTEND TIME for Defendants to file their Answering Brief to IGI's Motion to Dismiss Counterclaim to March 5, 2014 and for IGI t...
Entry #β€” • 2014-02-14

Docket Entries

(42 total)
Pleading / Complaint

COMPLAINT FOR DECLARATORY JUDGMENT filed against Mallinckrodt Inc., Mallinckrodt LLC, Nuvo Research Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1428925.) - filed by IGI Laboratories Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(dmp, ) (Entered: 12/20/2013)

Entry #1 • 2013-12-19
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 12/20/2013)

Entry #2 • 2013-12-19
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/25/2013. Date of Expiration of Patent: 078-7/10.29; 450-8/9/30. No thirty month stay deadline. (dmp, ) (Entered: 12/20/2013)

Entry #3 • 2013-12-19
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,217,078 B1; US 8,546,450 B1;. (dmp, ) (Entered: 12/20/2013)

Entry #4 • 2013-12-19
1

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by IGI Laboratories Inc.. (Schladweiler, Benjamin) (Entered: 12/20/2013)

Entry #5 • 2013-12-20
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc